Evidence map›Paper›PMID 33567522›Full record

ArticleJournal of clinical medicine2021

Cytotoxicity and Epidermal Barrier Function Evaluation of Common Antiseptics for Clinical Use in an Artificial Autologous Skin Model.

María I Quiñones-Vico, Ana Fernández-González, Elena Pérez-Castejón, Trinidad Montero-Vílchez, Salvador Arias-Santiago

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Antibiotics againstPharmaceutics · 2024
    Article
  2. Article
  3. Advances in Translational Regenerative Therapies.Journal of clinical medicine · 2023
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

María I Quiñones-VicoCell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, Spain.ORCID 0000-0002-4984-1017
Ana Fernández-GonzálezCell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, Spain.ORCID 0000-0001-6852-0836
Elena Pérez-CastejónCell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, Spain.
Trinidad Montero-VílchezBiosanitary Institute of Granada (ibs. GRANADA), 18014 Granada, Spain.ORCID 0000-0003-4035-7955
Salvador Arias-SantiagoCell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, Spain.
Instituto de Investigación Biosanitaria de Granada · ESUniversidad de Granada · ES

Funding

Instituto de Salud Carlos III PI13/02576Instituto de Salud Carlos III PI17/02083Junta de Andalucía SAS PI-0458-2016Ministerio de Ciencia, Innovación y Universidades BOE 22/10/2019
6 · The paper itself

Abstract

Bioengineered artificial skin substitutes (BASS) are the main treatment used in addition to autografts when skin injuries involve a large body surface area. Antiseptic/antibiotic treatment is necessary to prevent infections in the BASS implant area. This study aims to evaluate the effect of antiseptics and antibiotics on cell viability, structural integrity, and epidermal barrier function in BASS based on hyaluronic acid during a 28 day follow-up period. Keratinocytes (KTs) and dermal fibroblasts (DFs) were isolated from skin samples and used to establish BASS. The following antibiotic/antiseptic treatment was applied every 48 h: colistin (1%), chlorhexidine digluconate (1%), sodium chloride (0.02%), and polyhexanide (0.1%). Cell viability (LIVE/DEAD

Indexed as

antiseptic/antibiotic testingbioengineered artificial skin substitutecell viabilityepidermal barrier functionregenerative medicinewound healing

Identifiers

PMID33567522
PMCPMC7914612
OpenAlexW3128076661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.